Date:25 November, 2013

Advanced Alpha-1 Screening

CSL Behring has announced the availability of DNA1 Advanced Alpha-1 ScreeningTM (DNA1), a new test that aims to improve diagnosis of Alpha-1 Antitrypsin Deficiency (Alpha-1). Launched during Alpha-1 Awareness Month, DNA1 is the only comprehensive Alpha-1 test available that identifies known and unknown clinically relevant genetic variants to help physicians achieve an accurate diagnosis.

Read more: http://www.cslbehring.com/newsroom/Innovative-Alpha-1-Test-Aims-to-Improve-Diagnosis